| Trial ID: | L2292 |
| Source ID: | NCT00704574
|
| Associated Drug: |
Insulin Detemir
|
| Title: |
Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 Diabetes
|
| Acronym: |
PREDICTIVE™
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin detemir
|
| Outcome Measures: |
Primary: Incidence of serious adverse drug reactions, including major hypoglycaemic events, after 6 month treatment | Secondary: Number of all hypoglycaemic events, after 6 month treatment|Number of adverse drug reactions, after 6 month treatment|BMI changes, after 6 month treatment|HbA1c, after 6 month treatment|Variability in FPG (Fasting Plasma Glucose), after 6 month treatment
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
|
| Enrollment: |
159
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2008-01
|
| Completion Date: |
2010-06
|
| Results First Posted: |
|
| Last Update Posted: |
2017-01-31
|
| Locations: |
Novo Nordisk Investigational Site, Lund, 221 85, Sweden
|
| URL: |
https://clinicaltrials.gov/show/NCT00704574
|
